CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy
Sun Ae Han, Young Min Yoon, Wan Soo Lee, Yun Sung Kim, Byung Chul Shin, Jong Hoon Chung, Hyun Lee Kim
Korean J Intern Med. 2016;31(3):601-604.   Published online 2016 March 7    DOI: https://doi.org/10.3904/kjim.2014.292

Excel Download

Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy
The Korean Journal of Internal Medicine. 2016;31(3):601-604   Crossref logo
Link1 Link2 Link3

Clinical outcomes after withdrawal of anti-tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: A twelve-year experience
Arthritis & Rheumatism. 2011;63(10):3163-3168   Crossref logo
Link1 Link2 Link3

Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid Arthritis
Advances in Therapy. 2016;33(5):807-823   Crossref logo
Link1 Link2 Link3

Tumor necrosis factor inhibitors and cancer in juvenile idiopathic arthritis: Disentangling the web
Arthritis & Rheumatism. 2012;64(4):966-969   Crossref logo
Link1 Link2

Tumour necrosis factor alpha promoter polymorphisms and etanercept therapy in juvenile idiopathic arthritis
Rheumatology International. 2006;27(4):383-386   Crossref logo
Link1 Link2 Link3

Genotoxicity of anti–tumor necrosis factor therapy in patients with juvenile idiopathic arthritis
Arthritis Care & Research. 2010;62(1):73-77   Crossref logo
Link1

Evolution of dermatomyositis during therapy with a tumor necrosis factor α inhibitor
Arthritis & Rheumatism. 2006;55(6):982-984   Crossref logo
Link1 Link2

Endogenous and Exogenous Tumor Necrosis Factor Therapy: EET Therapy
Tumor Necrosis Factor / Cachectin and Related Cytokines. ;210-213   Crossref logo
Link1 Link2

Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy
Advances in Therapy. 2017;34(8):1936-1952   Crossref logo
Link1 Link2 Link3

Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis
Arthritis & Rheumatology. 2016;68(6):1337-1345   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.